Twist Bioscience
The Amazon of DNA
South San Francisco, California, United States
Twist Bioscience is a public biotechnology company manufacturing synthetic DNA and DNA products using a proprietary semiconductor-based process. Their innovative method allows for faster and more affordable production of high-quality synthetic DNA, used in products like synthetic genes and antibody libraries for drug discovery.
How We Help
Problem Statement
Twist Bioscience addresses the limitations of traditional DNA synthesis regarding throughput, cost, and scalability, which previously hindered the industrialization and broader application of engineered biology. Their platform overcomes these challenges to make synthetic DNA production faster, more affordable, and at an industrial scale.
Core Technology
proprietary semiconductor-based synthetic DNA manufacturing process, writing DNA on a silicon chip
Key Differentiators
faster and more affordable manufacturing of high-quality synthetic DNA
Clinical Focus
Cancer Research (detection, diagnostics, MRD testing, liquid biopsy, tumor profiling, hereditary oncology), Infectious Diseases (detecting and surveilling novel viral pathogens, SARS-CoV-2, monkeypox, universal flu vaccines), Drug Discovery & Biologics (antibody discovery and optimization for autoimmune, metabolic, and neurological diseases), Rare Diseases (whole exome analysis and focused rare disease-related sequences).
Target Customers
A wide range of industries, including synthetic biology, biopharma (drug discovery, biologics), and NGS tools customers (for cancer research, infectious diseases, rare diseases).
Product Stage
Mature
Company Info
- Business Model
- Operates a digital-to-biological manufacturing model, providing synthetic DNA-based products and services. Business segments include Synthetic Biology, NGS Tools, and Biopharma Services. Aims to be a foundational B2B provider of synthetic DNA, often described as the 'Amazon of DNA.'
- Founded
- 2013
- Total Funding
- 553,100,000
- Website
- www.twistbioscience.com
Categories
Disease Areas
Technologies
Clinical & IP
IP Protection
Strong patent portfolio.
MedStartr Index Score
?What do you think of Twist Bioscience?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.